Suppr超能文献

[在对氯喹高度耐药地区的单纯性疟疾发作。3. 二线口服药物治疗的应用]

[Uncomplicated malaria attack in an area with high resistance to chloroquine. 3. The use of second-choice oral drug treatment].

作者信息

Hengy C, Eberlé F, Gazin P, Kouka-Bemba D, Gelas H, Jambou R

机构信息

OCEAC.

出版信息

Bull Soc Pathol Exot. 1990;83(1):61-5.

PMID:2190706
Abstract

This study appreciated the efficiency of uncomplicated malaria second line treatment (P. falciparum) in an area with high level of chemoresistance. No therapeutic failure was found with sulfadoxine-pyrimethamine (Fansidar), and mefloquine-sulfadoxine-pyrimethamine (Fansimef), in contrast with a rate of 8% with quinine. The authors discuss the place of these therapeutic, in the treatment of malaria.

摘要

本研究评估了在耐药性较高地区单纯性疟疾二线治疗(恶性疟)的疗效。与奎宁8%的治疗失败率相比,磺胺多辛-乙胺嘧啶(Fansidar)和甲氟喹-磺胺多辛-乙胺嘧啶(Fansimef)未发现治疗失败情况。作者讨论了这些治疗方法在疟疾治疗中的地位。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验